TRIM5α from the rhesus macaque (TRIM5α Rh ) is a restriction factor that shows strong activity against HIV-1. TRIM5α Rh binds specifically to HIV-1 capsid (CA) through its B30.2/PRYSPRY domain shortly after entry of the virus into the cytoplasm. Recently, three putative SUMO interacting motifs (SIMs) have been identified in the PRYSPRY domain of human and macaque TRIM5α.
Introduction
Proteins from the TRIM5 family are known for their restriction activity against retroviruses [1, 2, 3, 4] . Restriction mediated by TRIM5α relies on its ability to recognize the viral CA core shortly after entry of the virus in the cell, in a virus-specific and species-specific manner [ 9 _ T D $ D I F F ] [5] . TRIM5α contains RING, B-Box, coiled-coil (RBCC) domains [6, 7] and the C-terminal SPRY domain (also called B30. 2 [11]. The B-Box and coiled-coil domains are involved in TRIM5α Rh dimerization and higher-order multimerization, properties that are likely important for the formation of cytoplasmic bodies (CBs) observable by light microscopy [12, 13, 14] . The RING domain has E3-ubiquitin ligase activity essential for auto-ubiquitylation of the protein and efficient restriction [ 1 4 _ T D $ D I F F ] [15] .
Interactions between TRIM5α and the retroviral CA N-terminal domain destabilize the CA lattice [16, 17, 18, 19, 20] . As a result, the CA core undergoes disassembly and some of its components are degraded, as well as TRIM5α itself [20, 21, 22] . TRIM5α also impairs viral transport to the nucleus [23, 24] . Another function has recently been attributed to TRIM5α: the Article No~e00056 activation of innate immunity pathways dependent on AP-1 and NF-κB [25, 26] .
The RING domain recruits the E2-ubiquitin conjugating enzyme heterodimer Ubc13 (Ube2N)/Ube2V2 (Uev2) to generate lysine 63 (K63)-linked polyubiquitin chains that can be anchored onto TRIM5α through the action of another E2 enzyme, Ebe2W [ 1 5 _ T D $ D I F F ] [27] . The presence of K63-linked ubiquitin chains has been proposed to be important for AP-1 and NF-κB transactivation [26, 28] .
Activation of NF-κB and AP-1 by TRIM5α is triggered by contact with a restriction sensitive virus [ [32] . SUMOylation is a post-translational modification involved in many cellular pathways [32, 33] . SUMO modifies targeted proteins through its covalent attachment to lysines present in a specific Nonetheless, recent publications have proposed a role for SUMO-1 in retroviral TRIM5α-mediated restriction [36, 37, 38] . The predicted SUMOylated lysine present in TRIM5α Rh promotes AP-1 and NF-κB signaling pathways through modulation of the RING domain activity [ 2 4 _ T D $ D I F F ] [30] . Moreover, it has been recently found that mutating the putative SIM1 and SIM2 impairs TRIM5α-mediated NF-κB activation and retroviral restriction, while mutating SIMs had no significant effect [36, 38, 39] . However, structural data revealed that the phenotypes of SIM1 and SIM2 mutants were probably a consequence of PRYSPRY misfolding. Indeed, these motifs appear to be buried deep inside the hydrophobic core of the PRYSPRY domain, making interactions with other proteins unlikely [ 2 5 _ T D $ D I F F ] [39] , although it cannot be excluded that contact with CA might result in structural changes that expose SIM1 and SIM2. In light of these results, we re-analyzed the PRYSPRY sequence for the presence of other possible SIMs and uncovered a novel putative SIM which we named SIM4.
Unlike putative SIMs 1 and 2, SIM4 residues are present at the surface of the protein, making this motif more suitable for interaction with other proteins. Here we demonstrate the importance of this motif in HIV-1 restriction and in the activation of NF-κB and AP-1. We propose that this signaling function is achieved by mediating interactions with an unidentified SUMOylated protein.
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Results
Identification of a new putative SUMO interacting motif in TRIM5α Rh
New insights into TRIM5α Rh (Fig. 1A) To investigate the potential role of SIM4 in TRIM5α Rh-mediated HIV-1 restriction, the two first aminoacids were mutated to lysines, thus mimicking the mutations that had been introduced in the other putative SIMs (Fig. 1D) . The mutants of putative SIMs 1 and 3 described by others [36, 38, 39] were also included in this study, while SIM2 was not included since its phenotype was identical to that of SIM1 [36, 38, 39 Fig. 2A) . Expression of V435K-I436K TRIM5α Rh resulted in a very small decrease in HIV-1 permissiveness (less than 2-fold), showing that the ability of this TRIM5α Rh mutant to restrict HIV-1 was almost completely lost ( Fig. 2A) .
Levels of protein expression were similar for all mutants, except for I376K-L377K whose expression level was decreased (Fig. 2B ), as previously seen by others [38, 39] . Therefore, the V435K-I436K mutation affects restriction of incoming HIV-1 seemingly without altering protein levels, unlike I376K-L377K which reduces both.
We investigated the ability of WT and V435K-I436K TRIM5α Rh to physically interact with HIV-1CA-NC complexes in a CA-binding assay in vitro [41, 42] .
Briefly, purified and assembled HIV-1CA-NC complexes were mixed with TRIM5α Rh proteins, which were over-expressed in and isolated from HEK293T cells. The mixture was then applied to a 70% sucrose cushion and following centrifugation, pellets and supernatants were analyzed by Western blotting. In this assay, binding of TRIM5α Rh to HIV-1CA is evidenced when both are present in the pellet fraction. This analysis had previously been conducted for I376K-L377K and I430K-V431K TRIM5α Rh , and results obtained were consistent with their restriction phenotype since I430K-V431K was found to bind HIV-1CA-NC complexes while I376K-L377K did not [ 2 6 _ T D $ D I F F ] [39] . Similarly to I376K-L377K, V435K-I436K TRIM5α Rh failed to bind HIV-1CA-NC complexes (Fig. 2C) , hence explaining its inability to restrict this virus.
HIV-1 restriction by TRIM5α correlates with co-localization of both proteins following infection, suggesting the existence of a "sequestration" mechanism of
. To investigate TRIM5α-CA interactions in a cellular context, we assessed the co-localization of FLAG-tagged WT, I376K-L377K or [15, 22] , but they used different cell lines.
The rate of decay for a given protein can vary depending on the cell type used and growth conditions [45, 46] . Using a two-way ANOVA followed by Dunnett's multiple comparison test, we found no statistically significant differences for I430K-V431K and V435K-I436K when compared to WT TRIM5α Rh in this assay (P values = 0.8832 and 0.3038, respectively). On the other hand, I376K-L377K stability was significantly decreased (P < 0.0001), supporting the misfolding hypothesis.
TRIM5α has the capacity to shuttle between the nucleus and the cytoplasm, and the fraction of the protein present in the nucleus can be enriched by treatment with the CRM-1/exportin 1 inhibitor leptomycin B (LMB) [39, 47, 48] . In the presence of this drug, TRIM5α Rh forms nuclear bodies (NBs) that co-localize with promyelocytic leukemia (PML) bodies In presence of LMB, WT TRIM5α Rh could be found in both cytoplasmic and nuclear compartments as expected (Fig. 3B ). I376K-L377K TRIM5α Rh was not observed in the nucleus, as previously reported [ 2 6 _ T D $ D I F F ] [39] . Interestingly, the distribution of V435K-I436K was similar to that of the WT protein, showing that mutating this motif did not affect nuclear translocation (Fig. 3B ).
The relatively large size of V435K-I436K TRIM5α Rh CBs ( Fig. 3B ) prompted us to analyze the potential of this mutant to multimerize. CRFK cells stably expressing WT or V435K-I436K TRIM5α Rh were lysed and the lysates were treated with increasing concentrations of glutaraldehyde, a crosslinking agent previously used in similar experiments [49, 50] . As shown in Fig. 3C , in the absence of glutaraldehyde we observed only monomers of TRIM5α Rh -FLAG (approximately 54 kDa). Multimers of V435K-I436K TRIM5α Rh were present in greater relative amounts, regardless of the glutaraldehyde concentration used, compared to the WT (Fig. 3C ). This suggests that this mutation increases TRIM5α Rh multimerization potential, explaining the enlarged CBs. Altogether, the results shown in Fig. 2 and Fig. 3 suggest that V435K-I436K disrupts restriction by affecting surface determinants of interaction with CA, although we cannot exclude that its effects on multimerization patterns also play a role. 
V435K-I436K abolishes the ability of TRIM5α Rh to activate AP-1 and NF-κB
TRIM5α is a pattern recognition receptor that promotes the activation of innate immune signaling pathways dependent on transcription factors AP-1 and NF-κB [25, 26, 29, 30] . These innate immune pathways result in the production of various inflammatory cytokines and chemokines calculated at each glutaraldehyde concentration. Standard deviation bars are shown on the graph and the P value was calculated using a two-way ANOVA statistical test. * points to a non-relevant band detected by the antibody used.
Article No~e00056 compared to cells transfected with the WT plasmid (∼65-fold for I376K-L377K and ∼11-fold for V435K-I436K TRIM5α Rh ; P < 0.0001). Levels of TRIM5α expression were similar for the WT and the various mutants, with the exception of I376K-L377K which showed reduced expression levels (Fig. 4B) . Therefore, the inability of V435K-I436K TRIM5α Rh to activate NF-κB was not caused by decreased expression levels. On the other hand, I376K-L377K TRIM5α Rh low expression levels partly explain the very low levels of NF-κB induction for this mutant (Fig. 4A) . However, higher protein amounts were observed when 3 μg of I376K-L377K TRIM5α Rh were transfected than when 0.3 μg of either WT or I430K-V431K TRIM5α Rh were used (Fig. 4B) , while NF-κB activation was readily detected for WT and I430K-V431K but not for I376K-L377K TRIM5α Rh in these same conditions (Fig. 4A) . Thus, we conclude that both I376K-L377K and V435K-I436K mutants are deficient for NF-κB activation.
To evaluate the effects of mutating the TRIM5α Rh SIMs on AP-1-dependent transactivation, HEK293T cells were co-transfected with 1 or 3 μg of WT, I376K-L377K, I430K-V431K or V435K-I436K TRIM5α Rh and with 0.6 μg of a reporter plasmid expressing luciferase under the control of the AP-1 response
. WT and I430K-V431K TRIM5α Rh significantly activated AP-1 at both DNA concentrations compared to the empty vector control (Fig. 4C ). On the other hand, I376K-L377K and V435K-I436K TRIM5α Rh were very weak activators of AP-1, as evidenced by low luciferase signal in both cases.
Specifically, when 3 μg of the TRIM5α Rh -expressing plasmid were used, WT and I430K-V431K TRIM5α Rh increased luciferase activity by ∼21-fold and ∼9-fold relative to the empty vector control, respectively (P < 0.0001) while I376K-L377K and V435K-I436K TRIM5α Rh increased it by only ∼2.3-fold (P = 0.1957) and ∼2.2-fold (P = 0.2304), respectively. Thus, these two mutants did not activate AP-1 to significant levels, while they resulted in a very significant (P < 0.0001) decrease in activation levels when compared to the WT (Fig. 4C) . Levels of protein expression were determined in the transfected cells by Western blot analysis (Fig. 4D ) and we found that V435K-I436K TRIM5α Rh was expressed at WT-like levels while I430K-V431K TRIM5α Rh was expressed at smaller levels (a 2-to 3-fold decrease). This explains that in the experiment shown in Fig. 4C , AP-1 activation by I430K-V431K TRIM5α Rh is similarly less efficient than for the WT control. On the other hand, the inability of I376K-L377K and V435K-I436K to activate AP-1 does not result from poor expression levels in HEK293T cells. Altogether, we conclude that V435K-I436K
TRIM5α Rh is unable to activate both AP-1 and NF-κB signaling pathways, suggesting that this motif is a determinant for innate immune signaling.
Mutating putative SIMs does not hinder the capacity of TRIM5α Rh to trigger K63-linked polyubiquitin chains formation
E3 ubiquitin ligase activity associated with the RING domain is essential for the ability of TRIM5α to promote formation of K63-linked ubiquitin chains [26, 52] that can then mediate the activation of AP-1 and NF-κB signaling through K63-linked ubiquitin chains were detected between ∼70 and 300 kDa, consistent with previous reports [26, 30] , and such polyubiquitylation products were almost undetectable in cells transfected with the KO ubiquitin mutant (Fig. 5A ).
The C35A TRIM5α Rh RING domain mutant was used as a negative control. As expected, K63-linked ubiquitin chains were almost undetectable in cells transfected with this mutant (Fig. 5A ). Co-transfection of WT, I376K-L377K, I430K-V431K and V435K-I436K TRIM5α Rh with WT ubiquitin resulted in strong stimulation of K63-linked polyubiquitylation, compared to cells co-transfected with TRIM5α Rh and KO ubiquitin or compared to cells co-transfected with the empty vector and WT ubiquitin (Fig. 5A, B) . A densitometry-based quantitative analysis was performed using Western blots from 3 independent experiments ( (Fig. 5B) . Specifically, all three SIM mutants showed statistically significant induction of K63-linked polyubiquitin when compared to the empty control while none of them showed statistically significant differences with the WT (Fig. 5B) . Therefore, the putative SIMs 1 and 4 are dispensable for the formation of K63-linked ubiquitin chains even though they are required for NF-κB and AP-1 activation. KO ubiquitin has all its lysines mutated to arginine to prevent polyubiquitylation. C35A TRIM5α Rh was used as a negative control for its incapacity to significantly promote K63-linked chains formation. Two days later, whole cell lysates were analyzed by Western blotting using rabbit antibodies directed at K63-linked ubiquitin chains or FLAG. A single experiment representative of three independent experiments is presented. * points to a non-relevant band detected by the antibody used. Samples were loaded on two gels due to space limitations but gels and blotting membranes were handled at the same time and in the exact same way. (B) Mean densities of bands ranging from 75 to >250 kDa detected using the K63 chains-specific antibody, normalized to the control consisting of cells co-transfected with WT-Ub and empty pMIP. Data were obtained in three independent experiments and standard deviations are shown. P values were calculated using a one-way ANOVA test for each TRIM5α variant compared to the empty vector control: *<0.05, **<0.01, ***<0.001. to encode VTIC. These data demonstrate that SIM4 is quite variable both between and within primate species.
V435K-I436K TRIM5α
All natural SIM4 variants were tested for their ability to activate NF-κB/AP-1 and restrict HIV-1. Using mutagenesis, we substituted TRIM5α Rh -SIM4 (VIIC) with all the natural variants (VKIC, VNIC, VTIC, VIVC, VIFC and MTIC), resulting in the production of 6 new proteins. First, their capacity to activate the M. fascicularis population, respectively) [70, 71] . These polymorphisms are indicated on the tree with hyphens, illustrating the alternate alleles that are co-circulating. Underlined names indicate primates that live in Continental Africa.
[ ( F i g . _ 7 ) T D $ F I G ]
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NF-κB and AP-1 signaling pathways was tested, as described above, using co-transfections in HEK293T cells. All the SIM4 variants were able to activate NF-κB (Fig. 8A ) and AP-1 (Fig. 8B ) since significant luciferase activity was observed in both experiments. The SIM4 variants seemed to show some level of reduction (∼15% to 60%) in their capacity to activate both pathways, compared to the WT, but this could largely be attributed to decreased expression levels (Fig. 8C, D) . In contrast, V435K-I436K TRIM5α Rh was unable to activate both signaling pathways, as expected. Taken together, these results suggest that, despite the emergence of variations within the SIM4 sequence among primates, its capacity to activate NF-κB and AP-1 is conserved.
The second function to be analyzed was TRIM5α capacity to inhibit HIV-1 infection. CRFK cells stably expressing all the SIM4 variants, V435K-I436K or WT TRIM5α Rh were challenged with increasing amounts of HIV-1-GFP and further analyzed by flow cytometry. As expected, WT TRIM5α Rh strongly inhibited HIV-1 ( Fig. 8E ) and V435K-I436K TRIM5α Rh failed to restrict HIV-1 and was only slightly less permissive than cells expressing the empty vector control. All the SIM4 variants restricted HIV-1 at an intermediate level: ∼8-fold less than WT and ∼6-fold more than the empty vector control, on average.
Levels of protein expression were determined by Western blotting and were found to be comparable in all transduced cells (Fig. 8E ). An upper unspecific band was detected by the anti-FLAG antibody, as previously observed in CRFK cells (Fig. 3C) . Thus, mutating VIIC into naturally occurring sequences found in other species affects TRIM5α Rh ability to optimally restrict HIV-1, consistent with this motif being involved in interactions with CA in addition to being important for NF-κB/AP-1 signaling. The fact that, for some of the mutants tested, the effect on NF-κB activation is much milder than the effect on restriction supports a model in which the two functions can have distinct determinants.
Discussion
In this study, we identified a new putative SIM (
PRYSPRY that is, on one hand, involved in specific interactions with the retroviral capsid, and on the other hand, is also essential for the activation of NF-κB/AP-1 at least in the infection-free model employed here. Mutating this motif impaired restriction (Fig. 2) and NF-κB/AP-1 signaling (Fig. 4) , while a similar mutation in the adjacent SIM3 Fig. 4, Fig. 5 ), this is probably due to overexpression conditions in this particular cell line. In contrast to I376K-L377K, the SIM4 mutant (V435K-I436K) was stable and able to shuttle to the nucleus (Fig. 3) indicating that this mutant was probably not misfolded, consistent with SIM4 being mostly a surface motif. However, V435K-I436K TRIM5α Rh shows increased potential for multimerization and CB formation (Fig. 3) . The TRIM5α coiled-coil and Linker2 domains upstream of SPRY form an anti-parallel homodimer which is expected to bring the SPRY domains in relatively close proximity [60, 61] , and it is conceivable that mutations in the proposed SIM4 could modulate interactions between the two PRYSPRY domains with negative consequences on restriction. In addition, it is possible that the larger size of the SIM4-mutated TRIM5α CBs means that less TRIM5α is available to intercept incoming HIV-1, contributing to the loss of restriction. . Here we show that the SIM4 double substitution mutant V435K-I436K completely disrupts the NF-κB/AP-1 activation potential of TRIM5α Rh , while mutating SIM3 has no effect (Fig. 4) .
It has been previously suggested that activation of NF-κB and AP-1 by TRIM5α is the consequence of a signaling cascade that includes the formation of . Interestingly, all the PRYSPRY mutants tested in this study were able to trigger significant formation of K63-linked ubiquitin chains (Fig. 5) . This result suggests that the various putative SIMs, and probably the PRYSPRY domain itself, are irrelevant to this function, at least in this overexpression experimental model. This conclusion is also supported by the fact that the SIM1 mutant can promote K63-linked ubiquitin despite its PRYSPRY domain being possibly misfolded. In contrast, mutating the RING zinc finger abolished this function (Fig. 5) , confirming that this domain is an essential determinant for the generation of K63-linked ubiquitin by TRIM5α Moreover, the fact that mutations in the putative SIM1 and SIM4 motifs abolish the stimulation of NF-κB and AP-1 indicates that presence of K63-linked polyubiquitin chains is not the sole requirement for activation of these innate immunity pathways. Thus, the SIM4 ( 435 VIIC 438 ) motif seems to be a determinant for an as yet unidentified activation step that is required for activation of NF-κB and AP-1 pathways. We cannot exclude, however, that the K63-linked ubiquitin chains generated by V435K-I436K TRIM5α Rh are defective in a way that could not be revealed by our Western blot analysis, or that they are not properly located in the cell to activate the NF-κB and AP-1 pathways. A direct role for SIM4 in activating NF-κB and AP-1 appears more likely, however, and we propose that SIM4 interacts with SUMO or an unidentified SUMOylated protein and that this interaction contributes to the activation of NF-κB/AP-1. The existence of such interactions was suggested by IF microscopy results (Fig. 6) . Taken together, these findings show that activation of NF-κB is extensively controlled by SUMOylation, providing several speculative models for TRIM5α interacting with a SUMOylated factor in order to promote innate immune activation. For instance, TRIM5α could interact, through the SIM4 motif, with SUMOylated IκBα to disrupt its interaction with NF-κB and thus promote NF-κB translocation to the nucleus. It is possible that the shuttling of TRIM5α in the nucleus and its transient association with PML bodies are important in its capacity to activate NF-κB and AP-1.
A phylogenetic analysis of the proposed SIM4 revealed some significant changes in some of the 36 primates analyzed (Fig. 7) . Six naturally occurring variants were tested for their ability to restrict HIV-1 when placed in a
TRIM5α Rh context and all were less efficient than their WT counterpart in this assay (Fig. 7E) , confirming that this motif is important for CA interactions in addition to being important for the activation of NF-κB/AP-1. Interestingly, intra-species polymorphism was found at this position in rhesus and crab-eating macaques. The analysis of NCBI TRIM5α sequences from 34 crab-eating macaques revealed 2 isolates bearing the motif VIVC, and 1 of 15 rhesus macaques had the motif VTIC. These species are already known for their polymorphism due to the occasional presence of a supplementary allele coding for TRIMCyp [70, 71] . Interestingly, individuals expressing the modified SIM4 (VIVC and VTIC) did not have the additional TRIMCyp allele. It is possible that TRIMCyp and SIM4 variants emerged in response to different viruses. The high level of polymorphism in SIM4 also supports a role for this motif in interacting with incoming retroviral CA cores. Of note, the VIIC motif is found in great apes and in OWM, the two primate groups living in Africa where one finds the most cases of SIV infections. It is possible that primates in other parts of the world do not undergo a strong selective pressure in order to make TRIM5α ultra-responsive towards lentiviruses. Interestingly, the ability to activate NF-κB and AP-1 was maintained for the six naturally occurring SIM4 variants tested here (Fig. 7) , suggesting that this function is essential and is evolutionarily conserved despite variations in the sequence that affect the capacity of these variants to restrict HIV-1 (Fig. 8 ). This observation supports the idea that the two functions are not necessarily coupled, even though interaction of TRIM5α with restriction sensitive viruses was shown to activate
In conclusion, we have characterized a new putative SIM ( 435 VIIC 438 ) in TRIM5α Rh that is important for TRIM5α-dependent innate immune signaling, possibly through its capacity to interact with SUMO or a SUMOylated protein, and which also has a role in the retroviral tropism of TRIM5α.
Materials and methods
Plasmid DNAs and mutagenesis
pMIP-TRIM5α Rh expresses a C-terminal FLAG-tagged version of TRIM5α Rh and has been described before [72, 73] . We designed the following primers to introduce mutations in pMIP-TRIM5α Rh : I376K-L377K, 5′-AAGTGCTTGGAAGAAGGGGGTATGTGCTGG-3′ (forward) and 5′-CATACCCCCTTCTTCCAAGCACTTTTCTT-3′ (reverse);
I430K-V431K, 5′-TGCTCCTTTCAAGAAGCCCCTCTCTGTGAT-3′ (forward) and 5′-CAGAGAGGGGCTTCTTGAAAGGAGCAAAAG-3′(reverse);
TCGTGTTG-3′ (forward) and 5′-CAACACGATCAGGACAAA-TCTTCTTAGAGAG GGGCACAATGAAAG-3′ (reverse). SIM4 variants were constructed using pMIP-TRIM5α Rh as template and mutations were introduced using the following primers: VKIC, 5′-GTGCCCCTCTCTGTGAAAATTTGTCCTGA-TCGTGTTG-3′ (forward) and 5′-GATCAGGACAAATTTTC-ACAGAGAGGGGCACAATGAAAG-3′ (reverse); VNIC,
5′-GTGCCCCTCTCTGTGAATATTTGTCCTGATCGTGTTG-3′ (forward) and 5′-GATCAGGACAAATATTCACAGAGAGGGGCACAATGAAAG-3′ (reverse); VTIC, 5′-GTGCCCCTCTCTGTGACTATTTGTCCTGATCGTGTTG-3′
(forward) and 5′-GATCAGGACAAATAGTCACAGAGAGGGG-CACAATGAAAG-3′ (reverse); VIVC, 5′-GTGCCCCTCTCTGT-GATTGTTTGTCCTGATCGTGTTG-3′ (forward) and 5′-GATCAGGACAAACAATCACAGAGAGGGGCACAATGAAAG-3′ (reverse); VIFC, 5′-GTGCCCCTCTCTGTGAAATTTTGTCCTGATCGTGTTG-3′
(forward) and 5′-GATCAGGACAAAATTTCACAGAGA-GGGGCACAATGAAAG-3′ (reverse); MTIC, 5′-GTGCCCCT-CTCTATGACTATTTGTCCTGATCGTGTTG-3′ (forward) and 5′-GATCAGGACAAATAGTCATAGAGAGGGGCACAATGAAAG-3′ (reverse). All mutations were confirmed by Sanger sequencing. The vector production plasmids pMD-G, pΔR8.9, pCL-Eco and pTRIP-CMV-GFP have all been extensively described elsewhere [44, 74, 75, 76) . pRK5-HA- 
Cell lines
Human embryonic kidney (HEK) 293T cells and Crandell-Rees feline kidney (CRFK) cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and antibiotics at 37°C, 5% CO 2 . All cell culture reagents were from HyClone (Thermo Scientific, Logan, UT, USA).
Transfections and virus production
MLV and HIV-1-based vectors were produced through transient transfection of HEK293T cells using polyethylenimine (MW 25,000; Polysciences, Warrington, PA) and collected as previously described [72, 77] . To produce the MLV-based MIP vectors, cells were transfected with the relevant pMIP plasmid and co-transfected with pCL-Eco and pMD-G. All stably transduced cell lines were produced as previously described [72, 77] . Successfully transduced CRFK cells were selected with 4 μg/ml of puromycin. To produce the GFP-expressing HIV-1 vector HIV-1 TRIP-CMV-GFP (nicknamed HIV-1-GFP), cells were co-transfected with pΔR8.9, pMD-G and pTRIP-CMV-GFP.
Viral challenges
CRFK cells were plated in 24-well plates at 30,000 cells per well and infected the next day with different amounts of HIV-1-GFP or using a defined multiplicity of infection (MOI). Two days post-infection, cells were trypsinized and fixed in 2% formaldehyde in a PBS solution. The % of GFP-positive cells was then determined by analyzing 10,000 cells using a FC500 MPL cytometer with the CXP software (Beckman Coulter). 
Western blotting
K63 ubiquitin chains formation assay
HEK293T cells were seeded in 12-well plates at a cell density leading to 80%
confluency. On the next day, cells were co-transfected with either WT or mutant FLAG-tagged TRIM5α (2 μg) and either WT or KO pRK5-HA-ubiquitin (0.5 μg). The "empty" plasmid pMIP was used as a negative control. Cells were lysed in RIPA buffer 48 h post-transfection and processed for Western blotting. A monoclonal human/rabbit chimeric K63-linked ubiquitin chains-specific antibody (clone Apu, Millipore) was used (1:1000 dilution) to detect K63 ubiquitin chains. HIV-1CA-NC was expressed and purified as previously described [39, 41] and further used for the binding assay. HEK293T cells were transfected with plasmids expressing either WT or V435K-I436K FLAG-tagged TRIM5α Rh .
Two days post transfection, cells were lysed as previously described [ 2 6 _ T D $ D I F F ] [39] . CA-NC complexes assembled in vitro were incubated with cell lysates for 1 h at room temperature. The mixture was then applied to a 70% sucrose cushion and centrifuged at 100,000 g for 1 h at 4°C. Following centrifugation, the supernatant was removed and pellet was resuspended in protein sample buffer. Western blotting was performed to detect TRIM5α Rh (anti-FLAG antibody, Cell Signaling) and HIV-1CA-NC (anti-CAp24 antibody, Immunodiagnostics).
Phylogenetic analysis
Primate gene sequences for TRIM5 were obtained from GenBank. TRIM5 exon 8 was sequenced from 5 additional primate species (bonobo, pileated gibbon, agile gibbon, yellow-cheeked gibbon and black mangabey). Primary and Article No~e00056
